251 related articles for article (PubMed ID: 18071049)
1. Treating ocular Myasthenia Gravis with inadequate evidence.
Roach ES
Arch Neurol; 2007 Dec; 64(12):1794-5. PubMed ID: 18071049
[No Abstract] [Full Text] [Related]
2. Immunosuppressive or surgical treatment for ocular Myasthenia Gravis.
Chavis PS; Stickler DE; Walker A
Arch Neurol; 2007 Dec; 64(12):1792-4. PubMed ID: 18071048
[No Abstract] [Full Text] [Related]
3. Ocular Myasthenia Gravis treatment: the case against prednisone therapy and thymectomy.
Gilbert ME; De Sousa EA; Savino PJ
Arch Neurol; 2007 Dec; 64(12):1790-2. PubMed ID: 18071047
[No Abstract] [Full Text] [Related]
4. Myasthenia gravis treatment: twelve years experience on 110 patients.
Valli G; Jann S; Premoselli S; Scarlato G
Ital J Neurol Sci; 1987 Dec; 8(6):593-601. PubMed ID: 3429218
[TBL] [Abstract][Full Text] [Related]
5. Ocular myasthenia gravis.
March GA; Johnson LN
J Natl Med Assoc; 1993 Sep; 85(9):681-4. PubMed ID: 8120928
[TBL] [Abstract][Full Text] [Related]
6. Thymectomy in the treatment of myasthenia gravis.
Gutmann L; Warden HE; Wertheimer RI; Riggs JE
W V Med J; 1985 Feb; 81(2):29-31. PubMed ID: 3856372
[No Abstract] [Full Text] [Related]
7. Long-term prednisone followed by thymectomy in myasthenia gravis.
Mann JD; Johns TR; Campa JF; Muller WH
Ann N Y Acad Sci; 1976; 274():608-22. PubMed ID: 1066998
[TBL] [Abstract][Full Text] [Related]
8. The immune system, Part 2: Myasthenia gravis.
Stephens A
Nurs Times; 1997 Nov 12-18; 93(46):56-9. PubMed ID: 9418490
[No Abstract] [Full Text] [Related]
9. Development of generalized myasthenia gravis in patients with ocular myasthenia gravis.
Papapetropoulos TH; Ellul J; Tsibri E
Arch Neurol; 2003 Oct; 60(10):1491-2. PubMed ID: 14568823
[No Abstract] [Full Text] [Related]
10. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic strategy in myasthenia gravis].
Tranchant C
Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
[TBL] [Abstract][Full Text] [Related]
12. Thymoma, myasthenia gravis, and other paraneoplastic syndromes.
Tormoehlen LM; Pascuzzi RM
Hematol Oncol Clin North Am; 2008 Jun; 22(3):509-26. PubMed ID: 18514130
[TBL] [Abstract][Full Text] [Related]
13. Ocular myasthenia gravis.
Lee AG
Curr Opin Ophthalmol; 1996 Dec; 7(6):39-41. PubMed ID: 10166551
[TBL] [Abstract][Full Text] [Related]
14. The effect of plasmapheresis on post-thymectomy ocular dysfunction.
Olanow CW; Roses AD; Fay JW
Can J Neurol Sci; 1981 May; 8(2):169-72. PubMed ID: 7296427
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis: generalized vs ocular, and children vs adults.
Wang HS
Arch Neurol; 2003 Oct; 60(10):1491; author reply 1492. PubMed ID: 14568824
[No Abstract] [Full Text] [Related]
16. [Plasma exchange combined with immunosuppressive therapy in myasthenia gravis].
Tanaka M; Nagai H; Mori S; Miyatake T; Shinada S
No To Shinkei; 1982 Jul; 34(7):699-703. PubMed ID: 7138697
[No Abstract] [Full Text] [Related]
17. [Indication of thymectomy and immunotherapies on myasthenia gravis].
Murai H
Rinsho Shinkeigaku; 2007 Nov; 47(11):875-6. PubMed ID: 18210823
[TBL] [Abstract][Full Text] [Related]
18. [Ocular manifestations of myasthenia. Apropos of 60 cases of myasthenia observed at the Dakar University Hospital Center].
Wade A; Kassir M; Ndiaye IP
J Fr Ophtalmol; 1986; 9(10):653-6. PubMed ID: 3819321
[TBL] [Abstract][Full Text] [Related]
19. Ocular myasthenia gravis.
Gilbert ME; Savino PJ
Int Ophthalmol Clin; 2007; 47(4):93-103, ix. PubMed ID: 18049283
[No Abstract] [Full Text] [Related]
20. [Respiratory insufficiency in myasthenia gravis].
Kuks JB; Hylkema BS; Oosterhuis HJ
Ned Tijdschr Geneeskd; 1985 May; 129(21):996-1000. PubMed ID: 4010810
[No Abstract] [Full Text] [Related]
[Next] [New Search]
